Forxiga HF General Drug Use-Results Study

Forxiga Tablets General Drug Use-Results Study in Patients With HF

To capture safety when Forxiga is administered to patients with HF in clinical practice after launch.

The purpose of the study is to review the following points during use of Forxiga Tablets (hereinafter referred to as Forxiga) in the real world setting after launch.

1. ADRs which are unexpected from the precautions for use
2. Understanding of incidence of ADRs during use of Forxiga in the real world setting
3. Factors possibly having an impact on the safety

Inclusion Criteria:

• Patients aged more than 15 years
• Patients who have been prescribed Forxiga for the first time

Exclusion Criteria:

• Patients with a history of hypersensitivity to any ingredients of this drug.
• Patients with severe ketosis, diabetic coma or precoma
• Patients with severe infections, before or after a surgery, or with serious trauma